First European patent granted for BioKier

BioKier has been informed by European Patent Office that the examining division intends to grant a European patent on the basis of the application # 10 729 620.4 The present invention relates to a method of treating an incretin related disease such as diabetes,...

US PTO has granted two new patents to BioKier

US PTO has granted BioKier patent 9,301,938 which was issued on April 5, 2016. The present invention relates to a method of treating obesity, diabetes and other metabolic diseases by fixed combination of BioKier’s product with monoamine reuptake inhibitors like...

Q&A: BioKier

Recently David Menzies from Carolina Tech News interviewed Dr George Szewczyk, CEO of BioKier, Inc. “There were numerous innovative companies participating in CED’s recent 2016 Life Science Conference earlier this month. As part of our mission to build a...

Two New Patents Announced

US PTO has granted BioKier patent 8,470,885 which published on June 25, 2013 Second BioKier patent issued by US PTO on 3/25/14; Patent Number: 8,680,085 Third BioKier patent issued by US PTO on 4/14/15; Patent Number:...